4/25/18: PHASE 3 IMMUNOTHERAPY STUDY SHOWS PROMISE IN ADVANCED NON-SMALL-CELL LUNG CANCER: Patients Who Received Keytruda® With Chemo Lived Longer Than Those Getting Chemo Alone